138 related articles for article (PubMed ID: 33141339)
21. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia.
Tsukamoto T; Inada K; Tanaka H; Mizoshita T; Mihara M; Ushijima T; Yamamura Y; Nakamura S; Tatematsu M
J Cancer Res Clin Oncol; 2004 Mar; 130(3):135-45. PubMed ID: 14655050
[TBL] [Abstract][Full Text] [Related]
22. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells.
Akiyama Y; Maesawa C; Ogasawara S; Terashima M; Masuda T
Am J Pathol; 2003 Nov; 163(5):1911-9. PubMed ID: 14578190
[TBL] [Abstract][Full Text] [Related]
23. Alteration in Methylation Pattern of Retinoblastoma 1 Gene Promotor Region in Intestinal Metaplasia with or without Helicobacter pylori and Gastric Cancer Patients.
Boyacioglu SO; Kasap E; Yuceyar H; Korkmaz M
Adv Clin Exp Med; 2016; 25(3):465-70. PubMed ID: 27629734
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and molecular stability and methylation analyses of gastric papillary adenocarcinoma.
Uesugi N; Sugai T; Sugimoto R; Eizuka M; Fujita Y; Sato A; Osakabe M; Ishida K; Koeda K; Sasaki A; Matsumoto T
Pathology; 2017 Oct; 49(6):596-603. PubMed ID: 28830689
[TBL] [Abstract][Full Text] [Related]
25. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation.
Kim KJ; Lee TH; Cho NY; Yang HK; Kim WH; Kang GH
Hum Pathol; 2013 Jun; 44(6):1055-64. PubMed ID: 23266441
[TBL] [Abstract][Full Text] [Related]
26. [Microsatellite instability and loss of heterozygosity in neoplastic and preneoplastic gastric lesions].
Roa JC; Araya JC; Villaseca MA; Roa I; Correa P
Rev Med Chil; 2003 Nov; 131(11):1227-36. PubMed ID: 14743682
[TBL] [Abstract][Full Text] [Related]
27. Absence of BAT-26 instability in gastric intestinal metaplasia.
Jin Z; Tamura G; Satoh M; Meguro T; Miura T; Hayashi M; Osakabe M; Ohmura K; Ogata S; Endoh Y; Motoyama T
Pathol Int; 2001 Jun; 51(6):473-5. PubMed ID: 11422810
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions.
Liao X; Lin R; Zhang Z; Tian D; Liu Z; Chen S; Xu G; Su M
J Natl Cancer Inst; 2024 May; 116(5):681-693. PubMed ID: 38258659
[TBL] [Abstract][Full Text] [Related]
29. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
30. Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation.
Takeuchi C; Yamashita S; Liu YY; Takeshima H; Sasaki A; Fukuda M; Hashimoto T; Naka T; Ishizu K; Sekine S; Yoshikawa T; Hamada A; Yamamichi N; Fujishiro M; Ushijima T
Gut; 2024 Jan; 73(2):255-267. PubMed ID: 37751933
[TBL] [Abstract][Full Text] [Related]
31. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands.
Shiotani A; Uedo N; Iishi H; Murao T; Kanzaki T; Kimura Y; Kamada T; Kusunoki H; Inoue K; Haruma K
J Gastroenterol; 2012 Sep; 47(9):988-98. PubMed ID: 22382634
[TBL] [Abstract][Full Text] [Related]
32. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
Lee HJ; Nam KT; Park HS; Kim MA; Lafleur BJ; Aburatani H; Yang HK; Kim WH; Goldenring JR
Gastroenterology; 2010 Jul; 139(1):213-25.e3. PubMed ID: 20398667
[TBL] [Abstract][Full Text] [Related]
34. Investigating FGFR2 gene as a blood-based epigenetic biomarker in gastric cancer.
Aleyasin SA; Moradi A; Abolhasani N; Abdollahi M
Mol Biol Rep; 2024 Feb; 51(1):253. PubMed ID: 38302798
[TBL] [Abstract][Full Text] [Related]
35. SOX2 Inhibition Promotes Promoter Demethylation of CDX2 to Facilitate Gastric Intestinal Metaplasia.
Niu H; Jia Y; Li T; Su B
Dig Dis Sci; 2017 Jan; 62(1):124-132. PubMed ID: 27913994
[TBL] [Abstract][Full Text] [Related]
36. DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.
Krishnan V; Lim DXE; Hoang PM; Srivastava S; Matsuo J; Huang KK; Zhu F; Ho KY; So JBY; Khor C; Tsao S; Teh M; Fock KM; Ang TL; Jeyasekharan AD; Tan P; Yeoh KG; Ito Y
Gut; 2020 Oct; 69(10):1738-1749. PubMed ID: 31937549
[TBL] [Abstract][Full Text] [Related]
37. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer.
Leung WK; Kim JJ; Kim JG; Graham DY; Sepulveda AR
Am J Pathol; 2000 Feb; 156(2):537-43. PubMed ID: 10666383
[TBL] [Abstract][Full Text] [Related]
39. Analysis of molecular alterations in laterally spreading tumors of the colorectum.
Sugai T; Habano W; Takagi R; Yamano H; Eizuka M; Arakawa N; Takahashi Y; Yamamoto E; Kawasaki K; Yanai S; Ishida K; Suzuki H; Matsumoto T
J Gastroenterol; 2017 Jun; 52(6):715-723. PubMed ID: 27704264
[TBL] [Abstract][Full Text] [Related]
40. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
